-
1
-
-
0037925438
-
Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease
-
Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR 2003 Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13:3-126
-
(2003)
Thyroid
, vol.13
, pp. 3-126
-
-
Baloch, Z.1
Carayon, P.2
Conte-Devolx, B.3
Demers, L.M.4
Feldt-Rasmussen, U.5
Henry, J.F.6
LiVosli, V.A.7
Niccoli-Sire, P.8
John, R.9
Ruf, J.10
Smyth, P.P.11
Spencer, C.A.12
Stockigt, J.R.13
-
2
-
-
77955300528
-
Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules
-
Kim ES, Lim DJ, Baek KH, Lee JM, Kim MK, Kwon HS, Song KH, Kang MI, Cha BY, Lee KW, Son HY 2010 Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules. Thyroid 20:885-891
-
(2010)
Thyroid
, vol.20
, pp. 885-891
-
-
Kim, E.S.1
Lim, D.J.2
Baek, K.H.3
Lee, J.M.4
Kim, M.K.5
Kwon, H.S.6
Song, K.H.7
Kang, M.I.8
Cha, B.Y.9
Lee, K.W.10
Son, H.Y.11
-
3
-
-
79955653371
-
Current thyroglobulin antibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer
-
Spencer C, Petrovic I, Fatemi S 2011 Current thyroglobulin antibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer. J Clin Endocrinol Metab 96:1283-1291
-
(2011)
J Clin Endocrinol Metab
, vol.96
, pp. 1283-1291
-
-
Spencer, C.1
Petrovic, I.2
Fatemi, S.3
-
4
-
-
0036173697
-
Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)
-
Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW,Spencer CA, Braverman LE 2002 Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489-499
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 489-499
-
-
Hollowell, J.G.1
Staehling, N.W.2
Flanders, W.D.3
Hannon, W.H.4
Gunter, E.W.5
Spencer, C.A.6
Braverman, L.E.7
-
5
-
-
16244386573
-
Thyroglobulin antibodies in serum of patients with differentiated thyroid cancer: Relationship between epitope specificities and thyroglobulin recovery
-
DOI 10.1373/clinchem.2004.044511
-
Okosieme OE, Evans C, Moss L, Parkes AB, Premawardhana LD, Lazarus JH 2005 Thyroglobulin antibodies in serum of patients with differentiated thyroid cancer: relationship between epitope specificities and thyroglobulin recovery. Clin Chem 51:729-734 (Pubitemid 40463924)
-
(2005)
Clinical Chemistry
, vol.51
, Issue.4
, pp. 729-734
-
-
Okosieme, O.E.1
Evans, C.2
Moss, L.3
Parkes, A.B.4
Premawardhana, L.D.K.E.5
Lazarus, J.H.6
-
6
-
-
60949101928
-
Thyroglobulin and anti-thyroglobulin assays in thyroid cancer monitoring
-
Krahn J, Dembinski T 2009 Thyroglobulin and anti-thyroglobulin assays in thyroid cancer monitoring. Clin Biochem 42:416-419
-
(2009)
Clin Biochem
, vol.42
, pp. 416-419
-
-
Krahn, J.1
Dembinski, T.2
-
7
-
-
0042021510
-
Thyroglobulin autoantibody levels below the cut-off for positivity can interfere with thyroglobulin measurement
-
Cubero JM, Rodríguez-Espinosa J, Gelpi C, Estorch M, Corcoy R 2003 Thyroglobulin autoantibody levels below the cut-off for positivity can interfere with thyroglobulin measurement. Thyroid 13: 659-661 (Pubitemid 36993562)
-
(2003)
Thyroid
, vol.13
, Issue.7
, pp. 659-661
-
-
Cubero, J.M.1
Rodriguez-Espinosa, J.2
Gelpi, C.3
Estorch, M.4
Corcoy, R.5
-
8
-
-
46149098430
-
In vitro assays to test the interference of anti-thyroglobulin antibodies on thyroglobulin measurement
-
Madureira D, Prazeres S, Pedro MS, Pereira T, Font AP, Bugalho MJ 2008 In vitro assays to test the interference of anti-thyroglobulin antibodies on thyroglobulin measurement. Endocrine 33:40-44
-
(2008)
Endocrine
, vol.33
, pp. 40-44
-
-
Madureira, D.1
Prazeres, S.2
Pedro, M.S.3
Pereira, T.4
Font, A.P.5
Bugalho, M.J.6
-
9
-
-
55349139657
-
Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry
-
Hoofnagle AN, Becker JO, Wener MH, Heinecke JW 2008 Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry. Clin Chem 54:1796-1804
-
(2008)
Clin Chem
, vol.54
, pp. 1796-1804
-
-
Hoofnagle, A.N.1
Becker, J.O.2
Wener, M.H.3
Heinecke, J.W.4
-
10
-
-
78650036862
-
Thyroid cancer recurrence in patients clinically free of disease with undetectable or very low serum thyroglobulin values
-
Kloos RT 2010 Thyroid cancer recurrence in patients clinically free of disease with undetectable or very low serum thyroglobulin values. J Clin Endocrinol Metab 95:5241-5248
-
(2010)
J Clin Endocrinol Metab
, vol.95
, pp. 5241-5248
-
-
Kloos, R.T.1
-
11
-
-
77953932599
-
Serum basal thyroglobulin measured by a second-generation assay correlates with the recombinant human thyrotropin-stimulated thyroglobulin response in patients treated for differentiated thyroid cancer
-
Spencer C, Fatemi S, Singer P, Nicoloff J, Lopresti J 2010 Serum basal thyroglobulin measured by a second-generation assay correlates with the recombinant human thyrotropin-stimulated thyroglobulin response in patients treated for differentiated thyroid cancer. Thyroid 20:587-595
-
(2010)
Thyroid
, vol.20
, pp. 587-595
-
-
Spencer, C.1
Fatemi, S.2
Singer, P.3
Nicoloff, J.4
Lopresti, J.5
-
12
-
-
33846121957
-
Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human TSHstimulated thyroglobulin in follow-up of thyroid cancer patients
-
Smallridge RC, Meek SE, Morgan MA, Gates GS, Fox TP, Grebe S, Fatourechi V 2007 Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human TSHstimulated thyroglobulin in follow-up of thyroid cancer patients. J Clin Endocrinol Metab 92:82-87
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 82-87
-
-
Smallridge, R.C.1
Meek, S.E.2
Morgan, M.A.3
Gates, G.S.4
Fox, T.P.5
Grebe, S.6
Fatourechi, V.7
-
13
-
-
0031791032
-
Serum thyroglobulin autoantibodies: Prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma
-
DOI 10.1210/jc.83.4.1121
-
Spencer CA, Takeuchi M, Kazarosyan M, Wang CC, Guttler RB, Singer PA, Fatemi S, LoPresti JS, Nicoloff JT 1998 Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 83:1121-1127 (Pubitemid 28496379)
-
(1998)
Journal of Clinical Endocrinology and Metabolism
, vol.83
, Issue.4
, pp. 1121-1127
-
-
Spencer, C.A.1
Takeuchi, M.2
Kazarosyan, M.3
Wang, C.C.4
Guttler, R.B.5
Singer, P.A.6
Fatemi, S.7
Lopresti, J.S.8
Nicoloff, J.T.9
-
14
-
-
0036138868
-
Importance of the detection method for thyroglobulin antibodies for the validity of thyroglobulin measurements in sera from patients with graves disease
-
Massart C, Maugendre D 2002 Importance of the detection method for thyroglobulin antibodies for the validity of thyroglobulin measurements in sera from patients with Graves disease. Clin Chem 48:102-107 (Pubitemid 34038128)
-
(2002)
Clinical Chemistry
, vol.48
, Issue.1
, pp. 102-107
-
-
Massart, C.1
Maugendre, D.2
|